SEC Filing Summary: GSK Plc (Form 6-K)
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated June 29, 2026, serves as a notification of a major holding change under UK Disclosure and Transparency Rules (DTR). The filing reports on an acquisition or disposal of voting rights by the institutional investor Dodge & Cox, with the threshold crossing occurring on June 24, 2026.
Key Financial Metrics
The filing text does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification regarding share ownership levels.
Material Changes
Dodge & Cox reduced its total voting rights in GSK Plc, crossing below the 5% notification threshold.
- Previous Position: 5.01% of voting rights (201,065,668 shares).
- Current Position: 4.96% of voting rights (201,065,668 shares).
- Composition: The holding consists of 2.19% in Ordinary Shares (ISIN: GB00BN7SWP63) and 2.77% in ADRs (ISIN: US37733W2044).
- Financial Instruments: No voting rights held through financial instruments (0.00%).
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a standard form notification (TR-1) regarding shareholder ownership.
Key Facts for Investor Verification
- Shareholder Action: Dodge & Cox's stake fell from 5.01% to 4.96%, dropping below the 5% regulatory reporting threshold.
- Share Count Consistency: The total number of voting rights listed for both the previous and current positions is identical (201,065,668), suggesting the percentage change may be due to a change in the total issued share capital of GSK Plc rather than a sale of shares by the investor.
- Notification Timing: The issuer was notified on June 26, 2026, two days after the threshold was crossed.
- Instrument Type: The holding is split between direct ordinary shares and American Depositary Receipts (ADRs).